Searched for
STERILE FORMULATIONS
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analysts- For risk-takers with long-term perspective: 10 small-cap stocks from different sectors with upside potential of up to 31%
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analysts
- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...02 May, 2026, 11.56 PM IST
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...29 Apr, 2026, 02.22 PM IST
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...27 Apr, 2026, 02.24 PM IST
- Quadria, PE funds eye stake in Samarth Lifesciences; deal may value firm at Rs 4,500 croreQuadria Capital is eyeing a strategic acquisition of a majority interest in Samarth Lifesciences, a move that could value the transaction a...23 Apr, 2026, 06.00 AM IST
- Market bets on Aurobindo as Europe, US sales show uptickAurobindo Pharma stock is performing well. Sales in Europe are improving. New products are launching in the US. The company is also develop...08 Apr, 2026, 06.56 AM IST
- Eris acquires 51 pc stake in Swiss Parenterals for Rs 637.5 crEris Lifesciences on Tuesday said it has acquired a 51 per cent stake in Swiss Parenterals for Rs 637.5 crore. Ahmedabad-based Swiss Parent...13 Feb, 2024, 07.21 PM IST
- Commerce ministry for imposing anti-dumping duty on pharma API from ChinaThe imposition of anti-dumping duty is permissible under the World Trade Organisation (WTO) regime. The duty is aimed at ensuring fair trad...29 Nov, 2021, 02.39 PM IST
- PAG to acquire contact manufacturer Acme FormulationFounded in 2005 by Viral Shah, Acme provides contract development and manufacturing services to major Indian and global pharmaceutical comp...22 Jul, 2021, 02.31 PM IST
- Shilpa Medicare shares hit lower circuit after USFDA observations for Telangana unitThe US Food and Drug Administration (USFDA) issued form 483 with 15 observations to the company’s Jadcherla Unit26 Feb, 2020, 01.23 PM IST
- Jubilant Life Sciences announces price hike of up to 15%Jubilant Life Sciences is engaged in pharmaceuticals, life science ingredients and drug discovery solutions.20 Dec, 2016, 05.32 PM IST
- Orchid Pharma gets EIR report from USFDA on inspection closureOrchid Pharma has received Establishment Inspection Report (EIR) from the US health regulator on the successful inspection closure for its ...31 Dec, 2015, 05.23 PM IST
- Swedish firm Recipharm buys majority stake in Nitin Lifesciences for Rs 671 croreSwedish contract drug manufacturing firm Recipharm has acquired a 74% stake in Nitin Lifesciences, a privately held sterile injectables man...21 Oct, 2015, 03.11 AM IST
- Pfizer may value Strides unit at Rs 10,000 crorePfizer's discussions with Strides Arcolab to acquire the latter's unit, Agila Specialties , is at a fairly advanced stage.12 Feb, 2013, 09.37 AM IST
- Strides Acrolab buys injectable facility for Rs 125 croreStrides Arcolab's wholly-owned subsidiary Agila Specialities acquired Sterile Formulations facility located at Hosur from Star Drugs and Re...27 Apr, 2012, 11.20 AM IST
- Strides Arcolab buys injectable facility for Rs 125 croreThe buy will give the Bangalore-based firm market advantage to set up and commercialise a Greenfield project that can take anywhere between...26 Apr, 2012, 05.55 PM IST
- NPIL Pharma to invest $50 mn by 200915 Feb, 2007, 04.00 PM IST
- Wockhardt gets US nod for Cefotaxime injectionWockhardt Ltd on Thursday said it has received approval from USFDA for marketing antibiotic Cefotaxime sodium injection in the US market.31 Aug, 2006, 11.40 PM IST
Load More
